Rajput Rajesh, Goel Vasudha
Departments of Medicine VI and Endocrinology, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India.
Indian J Endocrinol Metab. 2013 Oct;17(Suppl 1):S88-92. doi: 10.4103/2230-8210.119513.
Existing treatment modalities for Graves' disease includes antithyroid drugs (ATDs), radioactive iodine, and surgery. There has been a lack of general agreement as to which therapy is the best as none is ideal since all effectively restore euthyroidism, but with some limitations. Previously, therapies were selected with the goal of achieving euthyroidism. Instead, hypothyroidism is now the goal of treatment, to ensure that hyperthyroidism does not recur. Current evidences suggest that high relapse rate and not so rare fatal side effects seen with ATD therapy compel one to consider other definite modes of treatment like radiotherapy and surgery for toxic Graves' disease after discussing this with the patient.
目前治疗格雷夫斯病的方法包括抗甲状腺药物(ATD)、放射性碘和手术。对于哪种治疗方法是最佳的,一直缺乏普遍共识,因为没有一种方法是理想的,尽管所有方法都能有效恢复甲状腺功能正常,但都存在一些局限性。以前,选择治疗方法的目标是实现甲状腺功能正常。相反,现在治疗的目标是甲状腺功能减退,以确保甲亢不会复发。目前的证据表明,ATD治疗的高复发率和并不罕见的致命副作用迫使人们在与患者讨论后,考虑对毒性格雷夫斯病采用其他明确的治疗方式,如放疗和手术。